Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.

Blood
Matthew J ChristopherDaniel C Link

Abstract

Current evidence suggests that hematopoietic stem/progenitor cell (HSPC) mobilization by granulocyte colony-stimulating factor (G-CSF) is mediated by induction of bone marrow proteases, attenuation of adhesion molecule function, and disruption of CXCL12/CXCR4 signaling in the bone marrow. The relative importance and extent to which these pathways overlap or function independently are uncertain. Despite evidence of protease activation in the bone marrow, HSPC mobilization by G-CSF or the chemokine Grobeta was abrogated in CXCR4(-/-) bone marrow chimeras. In contrast, HSPC mobilization by a VLA-4 antagonist was intact. To determine whether other mobilizing cytokines disrupt CXCR4 signaling, we characterized CXCR4 and CXCL12 expression after HSPC mobilization with Flt3 ligand (Flt3L) and stem cell factor (SCF). Indeed, treatment with Flt3L or SCF resulted in a marked decrease in CXCL12 expression in the bone marrow and a loss of surface expression of CXCR4 on HSPCs. RNA in situ and sorting experiments suggested that the decreased CXCL12 expression is secondary to a loss of osteoblast lineage cells. Collectively, these data suggest that disruption of CXCR4 signaling and attenuation of VLA-4 function are independent mechanisms of mo...Continue Reading

References

Aug 1, 1968·The American Journal of Physiology·P A ChervenickM M Wintrobe
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·W H FlemingI L Weissman
Jan 1, 1997·Acta Haematologica·T Papayannopoulou, C Craddock
Dec 6, 2000·The Journal of Clinical Investigation·T PonomaryovT Lapidot
Apr 16, 2002·Current Opinion in Hematology·John ThomasDaniel C Link
May 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·Johannes F M PruijtWillem E Fibbe
Sep 20, 2002·Blood·Alois GratwohlUNKNOWN Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT)
Sep 25, 2002·Critical Reviews in Oncology/hematology·Louis M PelusAndrew G King
Aug 22, 2003·The New England Journal of Medicine·Bob LöwenbergUNKNOWN Swiss Group for Clinical Cancer Research
Dec 4, 2003·Molecular and Cellular Biology·Linda M ScottThalia Papayannopoulou
Mar 30, 2005·The Journal of Experimental Medicine·Ingrid G WinklerJean-Pierre Lévesque
Apr 20, 2005·The Journal of Experimental Medicine·Hal E BroxmeyerEdward F Srour
Sep 7, 2005·Statistics in Medicine·Theodore R Holford
Jan 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·Melissa van PelWillem E Fibbe
Sep 26, 2006·Nature Medicine·Liqing JinJohn E Dick
Mar 21, 2007·Bone Marrow Transplantation·A F CashenS M Devine
Jun 8, 2007·Handbook of Experimental Pharmacology·J-P LévesqueJ E J Rasko
Aug 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Angela C HirbeKatherine N Weilbaecher
Jun 10, 2008·Current Opinion in Hematology·Louis M Pelus
Jul 4, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Matthew J Christopher, Daniel C Link

❮ Previous
Next ❯

Citations

Oct 20, 2012·Cancer Metastasis Reviews·Stefan StefanovicChristoph Domschke
Oct 25, 2011·Cellular & Molecular Immunology·Ende ZhaoWeiping Zou
Sep 7, 2012·Leukemia·H Bonig, T Papayannopoulou
Feb 18, 2010·Nature Biotechnology·Yoriko SaitoFumihiko Ishikawa
May 20, 2011·Nature Reviews. Cancer·Katherine N WeilbaecherLaurie K McCauley
Sep 10, 2011·Nature Reviews. Immunology·Katherine Y King, Margaret A Goodell
Aug 3, 2010·Tissue Engineering. Part C, Methods·Yu-Suke TorisawaShuichi Takayama
Jul 13, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Avital MendelsonJeremy J Mao
May 4, 2011·Current Opinion in Hematology·Jonathan Hoggatt, Louis M Pelus
Nov 3, 2012·Journal of Biomedicine & Biotechnology·Yanqing Gong, Jane Hoover-Plow
Jun 17, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yusuke ShiozawaRussell S Taichman
Jun 3, 2010·The Journal of Clinical Investigation·Kyle J EashDaniel C Link
Mar 26, 2011·The Journal of Clinical Investigation·Laura G Schuettpelz, Daniel C Link
Aug 15, 2009·Blood·Jason Ross, Linheng Li
Jun 11, 2011·Respiratory Research·Annika Andersson-SjölandGunilla Westergren-Thorsson
Mar 23, 2011·Stem Cell Research & Therapy·Jonathan Hoggatt, Louis M Pelus
Apr 13, 2012·Biochemistry Research International·Neeta ShirvaikarAnna Janowska-Wieczorek
Oct 9, 2013·Calcified Tissue International·Laura M Calvi, Daniel C Link
Dec 22, 2009·Future Oncology·April A N Rose, Peter M Siegel
Apr 23, 2014·International Journal of Hematology·Evert-Jan F M de KruijfMelissa van Pel
Dec 29, 2011·Frontiers in Bioscience (Landmark Edition)·Dongsu ParkDavid T Scadden
Nov 3, 2011·Cellular and Molecular Life Sciences : CMLS·Ryan B Day, Daniel C Link
Sep 24, 2011·Expert Review of Hematology·Guro Kristin MelveOystein Bruserud
Nov 19, 2010·Expert Review of Hematology·Lloyd E Damon, Lauren E Damon
Aug 10, 2015·Biochimica Et Biophysica Acta·Emyr BakkerMarija Krstic-Demonacos
Jun 16, 2012·Immunology Letters·Sara M Rankin
Oct 23, 2010·Pharmacology & Therapeutics·Nicolle KränkelPaolo Madeddu
Sep 21, 2010·Bone·Jochen G SchneiderKatherine N Weilbaecher
Mar 2, 2016·Annals of the New York Academy of Sciences·Shiri Gur-CohenTsvee Lapidot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.